Search results
Results from the WOW.Com Content Network
The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. [30] In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. ASI designs manufactures, and delivers technologies used in bioprocessing. [31]
Life Technologies Corporation was a biotech company founded in November 2008 through a US $6.7 billion merger of Invitrogen Corporation and Applied Biosystems Inc. The joint sales of the combined companies were about $3.5 billion; they had about 9,500 employees and owned more than 3,600 licenses and patents.
Invitrogen was founded in 1987 by Lyle Turner, Joe Fernandez, and William McConnell and was incorporated in 1989. The company initially found success with its kits for molecular cloning—notably, The Librarian, a kit for making cDNA libraries, and the FastTrack Kit for mRNA isolation from biological samples.
Bottle of FBS for cell culture. Fetal bovine serum (FBS) is the most widely used serum-supplement for the in vitro cell culture of eukaryotic cells.This is due to it having a very low level of antibodies and containing more growth factors, allowing for versatility in many cell culture applications.
Tissue culture flasks. RPMI 1640, simply known as RPMI medium, is a cell culture medium commonly used to culture mammalian cells. [1] RPMI 1640 was developed by George E. Moore, Robert E. Gerner, and H. Addison Franklin in 1966 at Roswell Park Comprehensive Cancer Center (formerly known as Roswell Park Memorial Institute), from where it derives its name. [2]
Lipofectamine or Lipofectamine 2000 is a common transfection reagent, produced and sold by Invitrogen, used in molecular and cellular biology. [1] It is used to increase the transfection efficiency of RNA (including mRNA and siRNA) or plasmid DNA into in vitro cell cultures by lipofection. [1]
GIBCO Perspectives in Cell Culture; Invitrogen Guide to Serum-Free Culture; TNC Bio list of Chemically Defined products; Biological Industries (BI) list of Serum-Free media; Impact of surfactants in cell culture media on HEK and CHO cell cultivation and transfection; Fetal Calf Serum Free Database
Life Technologies, had been formed by the merger of GIBCO and Bethesda Research Laboratories in 1983. Clinical uptake of ViraPap was slow, and Life sold the test and associated intellectual property to Digene in 1990, soon after Digene was acquired by the Whitehead group.